Cargando…

Neoadjuvant therapy affects tumor growth markers in early stage non-small-cell lung cancer

INTRODUCTION: While adjuvant therapy of early-stage non-small-cell lung cancer (NSCLC) is widely accepted, literature data concerning neoadjuvant treatment provide contradictory results with both improved and unaffected survival rates. Also, data concerning potential effects of neo-adjuvant therapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chorostowska-Wynimko, J, Zaleska, J, Chabowski, M, Szpechcinski, A, Zych, J, Rudzinski, P, Langfort, R, Orlowski, T, Roszkowski-Sliz, K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521347/ https://www.ncbi.nlm.nih.gov/pubmed/20156723 http://dx.doi.org/10.1186/2047-783X-14-S4-42

Ejemplares similares

Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease
por: Szpechcinski, A, et al.
Publicado: (2015)

The expression of circulating miR-504 in plasma is associated with EGFR mutation status in non-small-cell lung carcinoma patients
por: Szpechcinski, Adam, et al.
Publicado: (2019)

Cryptogenic organizing pneumonia—Results of treatment with clarithromycin versus corticosteroids—Observational study
por: Radzikowska, Elżbieta, et al.
Publicado: (2017)

Real-time PCR quantification of plasma DNA in non-small cell lung cancer patients and healthy controls
por: Szpechcinski, A, et al.
Publicado: (2009)

FGFR1–4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2022)

Epidermal Growth Factor Receptor Mutation Status: Does Younger Mean More Frequently Mutated?
por: Wójcik, P, et al.
Publicado: (2017)

Post-Translational Modifications of Circulating Alpha-1-Antitrypsin Protein
por: Lechowicz, Urszula, et al.
Publicado: (2020)

Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung Cancer
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2022)

Targeted screening programmes in COPD: how to identify individuals with α(1)-antitrypsin deficiency
por: Chorostowska-Wynimko, Joanna
Publicado: (2015)

Pneumothorax in Patients with Pulmonary Langerhans Cell Histiocytosis
por: Radzikowska, E., et al.
Publicado: (2018)

SERPINA1 and More? A Putative Genetic Contributor to Pulmonary Dysfunction in Alpha-1 Antitrypsin Deficiency
por: Jezela-Stanek, Aleksandra, et al.
Publicado: (2023)

The importance of effective registries in pulmonary diseases and how to optimize their output
por: Chorostowska-Wynimko, Joanna, et al.
Publicado: (2019)

Endobronchial ultrasound–guided transbronchial needle aspiration in the staging of lung cancer patients
por: Dziedzic, Dariusz, et al.
Publicado: (2015)

Prevalence of cardiac sarcoidosis in white population: a case–control study: Proposal for a novel risk index based on commonly available tests
por: Martusewicz-Boros, Magdalena M., et al.
Publicado: (2016)

Video-assisted versus open thoracotomy lobectomy: comparison on lymphadenectomy and survival in early stage of lung cancer
por: Dziedzic, Dariusz A., et al.
Publicado: (2021)

New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency
por: Chorostowska-Wynimko, Joanna, et al.
Publicado: (2020)

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
por: Chapman, Kenneth R, et al.
Publicado: (2018)

The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions
por: Janciauskiene, Sabina, et al.
Publicado: (2018)

Neoadjuvant Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer
por: Sher, David J.
Publicado: (2017)

Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer
por: Shukla, Nikhil, et al.
Publicado: (2021)

Acute Phase Proteins as Early Predictors for Immunotherapy Response in Advanced NSCLC: An Explorative Study
por: Schneider, Marc A., et al.
Publicado: (2022)

Evaluation of the diagnostic utility of endobronchial ultrasound-guided transbronchial needle aspiration for metastatic mediastinal tumors
por: Dziedzic, Dariusz, et al.
Publicado: (2016)

The role of peripheral eosinophilia in diagnosing lung disorders: experience from a single pneumonological center
por: Fijolek, Justyna, et al.
Publicado: (2021)

Cardiac sarcoidosis: worse pulmonary function due to left ventricular ejection fraction?: A case-control study
por: Martusewicz-Boros, Magdalena M., et al.
Publicado: (2019)

Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?
por: Carleo, Alfonso, et al.
Publicado: (2017)

Effects of icotinib on early-stage non-small-cell lung cancer as neoadjuvant treatment with different epidermal growth factor receptor phenotypes
por: Wang, Tao, et al.
Publicado: (2016)

Three-Year Chronic Consumption of Low-Carbohydrate Diet Impairs Exercise Performance and Has a Small Unfavorable Effect on Lipid Profile in Middle-Aged Men
por: Pilis, Karol, et al.
Publicado: (2018)

Effect of Neoadjuvant Chemotherapy on the Serum Levels of Bone Turnover Markers in Women with Early-Stage Breast Cancer
por: Chen, YangYang, et al.
Publicado: (2015)

Asymptomatic appearance of splenic infarction in Wegener’s granulomatosis
por: Martusewicz-Boros, Magdalena, et al.
Publicado: (2011)

In Reply: Neoadjuvant TKI Study in Early- and Intermediate Stage Hepatocellular Carcinoma
por: Osanto, Susanne, et al.
Publicado: (2022)

Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small-Cell Lung Cancer, Past, Present, and Future
por: Szeto, Chun Ho, et al.
Publicado: (2021)

Diffuse pulmonary haemorrhage accompanied by haemothorax as a rare presentation of primary lung angiosarcoma
por: Modrzewska, Katarzyna, et al.
Publicado: (2015)

Neoadjuvant Dovitinib in Early- and Intermediate-Stage Hepatocellular Carcinoma
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Monitoring early responses to neoadjuvant chemotherapy and the factors affecting neoadjuvant chemotherapy responses in primary osteosarcoma
por: Yu, Hong, et al.
Publicado: (2023)

Neoadjuvant and Adjuvant Immunotherapy: Opening New Horizons for Patients With Early-Stage Non-small Cell Lung Cancer
por: Bai, Rilan, et al.
Publicado: (2020)

Alpha-1 Antitrypsin Z Variant (AAT PI*Z) as a Risk Factor for Intrahepatic Cholestasis of Pregnancy
por: Kosinski, Przemyslaw, et al.
Publicado: (2021)

Validation of Lung EpiCheck, a novel methylation-based blood assay, for the detection of lung cancer in European and Chinese high-risk individuals
por: Gaga, Mina, et al.
Publicado: (2021)

Methylation Markers of Early-Stage Non-Small Cell Lung Cancer
por: Lokk, Kaie, et al.
Publicado: (2012)

Neoadjuvant chemoimmunotherapy in resectable stage IIIA/IIIB non-small cell lung cancer
por: Chen, Yulong, et al.
Publicado: (2021)

Pathologic responses to neoadjuvant chemoimmunotherapy in primary limited‐stage small‐cell lung cancer
por: Lu, Meng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_19km9nhmesrnkpj5q8c3v1as4h